Forbes.com “Health. Care.” posts
June 30, 2011
mid-June 2011: four-part series, “Topics in Healthcare Innovation“:
- Part 1, June 17, 2011: “What Silicon Valley doesn’t understand about medicine“
- Part 2, June 21, 2011: “A cautionary prognosis for algorithm-based care“
- Part 3, June 22, 2011: “Why is medicine’s killer app an e-textbook?“
- Part 4, June 23, 2011: “Our metrics fetish — and what to do about it“
June 29, 2011: “Priests or mechanics? The tricky case for medical exceptionalism“
July 9, 2011: “What type of business person believes in personality tests?“
July 11, 2011: “‘Nevermind — it’s all good’ biopharma news roundup“
July 15, 2011: “The intelligent humility of phenotypic screening in drug discovery“
July 22, 2011: “Our grand challenge: translating clinical studies into clinical practice“
July 27, 2011: “The value of useful fictions in organizational management“
July 27, 2011: “Focus factor: should your doctor be thinking about society’s healthcare costs?“
August 30, 2011: “As therapeutics become personal, patient social networks may become more essential“
September 1, 2011: “Can progressive approvals cut regulatory’s Gordian Knot — and stimulate innovation?“
September 9, 2011: “Journovesting for fun and profit: eight who made the jump before Arrington“
September 15, 2011: “Michele Bachmann hearts the Whole Foods crowd?“
September 18, 2011: “How academic orthodoxy is enforced: a valuable lesson from a distinguished Pharmascold“
September 23, 2011: “Medicine’s next great challenge: returning science to patients” (co-author: Dr. Dennis Ausiello)
October 12, 2011: “Disease management, plus short takes on Kahneman, podcasts, merck, design thinking, consumer health“
October 17, 2011: “Passive-aggressive behavior = most valuable corporate trait? Interesting you should say that.”
October 18, 2011: “Finding (and supporting) rare talent: a challenge for biopharma — and universities“
October 23, 2011: “Does big pharma need entrepreneurial leadership?”
October 23, 2011: “Improved measurement: a path to better health for real people“
November 18, 2011: “Are doctors overly responsive to patients – or not attentive enough? (Answer: yes)“
November 22, 2011: “What a casino executive can teach doctors and job-seekers“
November 28, 2011: “Hey East Coast entrepreneurs: We fail better than you. XO – your friends in the Valley“
December 2, 2011: “Biopharma’s dirty secret revealed: science is fragile; forecasting is unreliable. Now deal with it.”
December 3, 2011: “Leaders of science-driven businesses should understand…science.”
December 21, 2011: “The most dangerous phrase: ‘Makes sense when you think about it’“
December 22, 2011: “Do something while you can“
December 24, 2011: “What do patients really want from health care?“
January 21, 2012: “Keen to drive science into medicine? Four lessons from an innovation conference.”
January 22, 2012: “Stossel is right for demonizing the demonization of physician-industry relationships“
January 27, 2012: “Road not taken: the unrecognized harm of excessive regulation“
February 3, 2012: “Do something really innovative in health: crowdsource problems, not (just) solutions“
February 7, 2012: “Getting better: online communities elevate voice of the patient“
February 10, 2012: “Turning loss into hope, family offers inspiration — and a few lessons about drug discovery“
February 11, 2012: “Medicine’s tech future: the view from the valley“
February 12, 2012: “Just in time for Valentine’s Day: biopharma + digital health?”
February 17, 2012: “Good start-up, bad corporation: the cost of trading passion for process“
February 22, 2012: “Can we really expect innovation from an industry stuck on white male former sales reps? Perhaps.”
February 23, 2012: “Reid Hoffman connects four themes for would-be innovators (and tomorrow’s healthcare companies)”
February 25, 2012: “Power couples: common in medicine, rare in business?“
March 9, 2012: “Prognosis for pharma: beatings to continue until morale improves?”
March 16, 2012: “Can mid-sized disruptors save the drug industry from a cubicle farm in Jersey?”
March 17, 2012: “WSJ to Biotech: ‘You’re all going to die.’ Thanks – now let’s keep fighting.”
March 23, 2012: “Forget bulls and bears: why are so many investors boors?”
March 26, 2012: “Curing type 2 diabetes with surgery: it works — now let’s figure out why“
March 29, 2012: “Curing cancer: too important — and too difficult — for university researchers to do alone“
March 30, 2012: “Saving Steve Jobs’ Legacy from a Successories Future“
March 31, 2012: “Medicine must allow for customization: a lesson for policy-makers — and regulators“
April 5, 2012: “Why the fragility of health outcomes research may be a good outcome for health“
Aporil 11, 2012: “Drugs vs Mobile: Two Ways to Create $1B in Value“
April 15, 2012: “The Real Danger of Medical Referrals: Physician Overconfidence + Lack of Quality Assessment“
April 22, 2012: “Translation, Innovation, Regulation: Responding to Biopharma’s Key Challenges “
May 11, 2012: “Quick take: will Sergey Brin cure Parkinson’s? Three lessons from his efforts.”
May 14, 2012: “Pills still matter; so does biology — managing expectations about digital health“
May 17, 2012: “Entrepreneurs are drawn by vision; managers are driven by process; transforming healthcare will require both“
May 19, 2012: “The real appeal of entrepreneurs, from Ira Glass to Zuck: Authorship of Life“
May 21, 2012: “Are digital health companies aiming too low — or is incremental improvement underappreciated?”
May 26, 2012: “Follow your heart? Lovely – but not what most business is about (alas).”
May 28, 2012: “Corporate innovation: a meme worth saving?”
May 28, 2012: “Is there a purity test for innovators?”
June 1, 2012: “End-of-life medical advice: devaluing patients in name of greater good?”
June 3, 2012: “Seriously: is digital health the answer to tech bubble angst?”
June 8, 2012: “Ten recent content picks you might have missed — none involving bath salts or Justin Bieber“
June 9, 2012: “Epic challenge: what the emergence of an EMR giant means for the future of healthcare innovation“ (w/Tory Wolff, Recon Strategy)
June 24, 2012: “Want to revolutionize health care? Enable physicians, don’t replace them.”
June 30, 2012: “Why you probably are already using the most powerful digital health app”
July 2, 2012: “Health = Potential x Attainment: two important, often distinct opportunities for entrepreneurs“
July 8, 2012: “Medicine and Silicon Valley: two cultures with more in common than you think“
July 12, 2012: “Cures matter, implementation too, aim high“
July 15, 2012: “How Dave McClure captures perfectly the agony and the ecstasy of Silicon Valley“
July 18, 2012: “What Mass General could learn from Barry Sanders“
July 20, 2012: “Why 500 Startups-style small bets could be next big idea in digital health“
July 27, 2012: “Time for biopharma to jump on the ‘big data’ train?”
July 29, 2012: “Couples pursuing two careers follow their hearts as much as their heads“
August 2, 2012: “A translational innovator career track to support health entrepreneurs“
August 3, 2012: “Space: still cool after all these years“
August 6, 2012: “Do you believe doctors are systems, my friends?” (discussion of Gawande/Cheesecake Factory article)
August 15, 2012: “Want to industrialize healthcare? Ask how well it has worked for pharma R&D“
August 16, 2012: “Closing the translational gap: a challenge facing innovators in medical science — and in digital health“
August 20, 2012: “Dyson and McClure: two investors one theme — VC as auteur“
September 1, 2012 “Why I Disagree With Vinod Khosla About Digital Health — And Hope He Succeeds Brilliantly“
September 3, 2012: “Digital health requires courages investors — and other lessons from the Khosla controversy“
September 5, 2012: “Interwebs roundup: recommended content“
September 9, 2012: “Obama vs Romney: founder CEO vs corporate executive?”
September 13, 2012: “Folly to forecast startup performance?”
September 26, 2012: “Better than Pandora for Cats: why LPs may be giving health VCs another look“
September 28, 2012: “No, most CEOs shouldn’t be on Twitter“
October 2, 2012: “Are successful VCs lucky or good — and can healthcare VCs be either?”
October 4, 2012: “Rigor and transparency: required for approval of drugs, needs for certification of providers“
October 8, 2012: “Silicon Valley: work-life balance is for losers, not closers“
October 10, 2012: “Digital health: almost a real, live business“
October 12, 2012: “Don’t confuse hard science with bad pharma“
November 4, 2012: “Good luck: why the year’s best business book says you’ll probably need it.”
November 5, 2012: “Is big pharma dangerously betting on huge, fragile product shots?”
November 6, 2012: “Big money, big money: the case for large pharma going large“
November 7, 2012: “Nate Silver’s prediction was awesome — but don’t build statues to ‘Algorithmic Overlords’ just yet“
November 9, 2012: “More diversity, less regulation: what American businesses can teach our politicians“
November 12, 2012: “The Mentalists: behavioral psychology delivered votes; can it now deliver health?
November 13, 2012: “Corporate wellness programs: better for waistline than bottom line?“
November 17, 2012: “Three lessons a hot midwestern weight-loss startup can teach us about digital health“
November 18, 2012: “It’s the platform, stupid: capturing the value of data in campaigns — and healthcare“
December 5, 2012: “My 2012 digital health awards: company, person, book of the year“
December 6, 2012: “Can digital health+sustainability lead to use-inspired innovation?”
December 11, 2012: “Can a graduate of Rock Health’s first class democratize diabetes prevention?”
December 22, 2012: “In praise of late bloomers and unconstrained thinkers“
December 24, 2012: “Three tensions in medical innovation to watch for in 2013“
December 27, 2012: “Focus on real problems in medicine and policy, not the industry affiliation sideshow“
December 30, 2012: “Turning information into impact: digital health’s long road ahead“
December 31, 2012: “To the meaningful pursuit of passion“
January 3, 2013: “Digital health companies must make themselves indispensable to established stakeholders“
January 7, 2013: “Rock tease: investors flirt with digital health but avoid serious commitment“
January 10, 2013: “Why not us? Time for better — basic — customer service in medicine“
January 11, 2013: “Are we the problem? The role of poor decision-making in stifling drug development“
January 11, 2013: “Workflow is the new plastics. Open EMRs should show, not tell.”
January 18, 2013: “Can a new org structure health drug developers make better early decisions?“
January 19, 2013: “Handle with care: success of digital health threatened by power of its technology“
January 21, 2013: “Family first: hoping Obama’s approach to work-life balance leads to believable change“
January 23, 2013: “Seeking balance, not purity, in medicine and drug development“
January 24, 2013: “Personalized regulation: more than just personalized medicine — and urgently required“
January 25, 2013: “Pharma’s digital health strategy: four options“
January 25, 2013: “We have a winner! Quick take on the Humedica acquisition by UnitedHealth“
February 5, 2013: “Massive hype — and hope — for digital health in silicon valley“
February 10, 2013: “Calling or career: the work doesn’t change — but the company may“
February 16, 2013: “Five take-aways from Whole Foods CEO John Mackey’s surprising new book“
February 18, 2013: “Fatal promotion: how VC’s and journalists may be killing entrepreneurs“
February 20, 2013: “Giving more prizes to established research stars questionable; appointing Topol editor of Medscape brilliant“
February 21, 2013: “Rock Health’s new class: daring to be useful“
March 3, 2013: “Procedures over patients: why the nurse who refused to perform CPR scares us about medicine’s guideline-driven future“
March 6, 2013: “Recipe for relevance: blend digital health developers and clinical providers“
March 7, 2013: “Does pharma’s innovation difficulties reflect bad leaders or tough circumstances?“
March 8, 2013: “Early-stage device companies vs biopharmas: who has it worst?“
March 11, 2013: “Opportunities for healthcare innovation SXSW hipsters may have missed“
March 12, 2013: “Case study: what would you do here if you were the payor? The Doctor? The patient?“
March 16, 2013: “Do no harm: to patients, or to populations?“
March 20, 2013: “Vision+passion: source of entrepreneurial success, or result of it?“
March 23, 2013: ”Strategy: Why big pharmas do what they do — and how Silicon Valley might help them think differently“
March 28, 2013: “Life science VCs: definitively indefinite about digital health“
April 2, 2013: “Goetz good get for Robert Wood Johnson, but where are the MDs in digital health investing?”
April 5, 2013: “The wild story behind a promising experimental cancer drug“
April 8, 2013: “Will the ‘Poc Pack become the PayPal Mafia of digital health?“
April 14, 2013: “Four reasons doctors worry about social media – #GetOverIt“
April 16, 2013: “Digital health: it’s on“
April 24, 2013: “Social media: more likely to identify bad medicines — or tarnish good ones?“
May 3, 2013: “Academics embrace digital health: bringing medicine and participation to medicine“
May 4, 2013: “PhD biopharma CEOs: better, bolder, or occasionally lucky?”
May 10, 2013: “What’s holding back cures? Our collective ignorance (and no, not a pharma conspiracy)“
May 15, 2013: “Two quick reactions to epic Faulkner interview: SV should show Judy more love; we shouldn’t let hospitals off the hook“
May 22, 2013: “Online mothers groups: powerful, unheralded influencers of family healthcare decisions“
May 23, 2013: “Hype, hope, and health in Silicon Valley“
